Results 161 to 170 of about 5,450,952 (343)

Molecular imaging predicts trastuzumab‐deruxtecan (T‐DXd) response in head and neck cancer xenograft models

open access: yesMolecular Oncology, EarlyView.
Trastuzumab‐deruxtecan, a HER2‐targeting antibody‐drug conjugate, shows promising antitumor activity in head and neck squamous cell carcinoma with low HER2 expression. In vitro and in vivo studies demonstrated dose‐dependent cell death and tumor growth reduction in low HER2‐expressing cell lines, which correlated with drug accumulation measured using a
Abdullah Bin Naveed   +8 more
wiley   +1 more source

N501Y mutation imparts cross-species transmission of SARS-CoV-2 to mice by enhancing receptor binding

open access: yesSignal Transduction and Targeted Therapy, 2021
Zubiao Niu   +9 more
doaj   +1 more source

A death or death situation [PDF]

open access: yesNature Reviews Molecular Cell Biology, 2002
openaire   +2 more sources

Loss of primary cilia promotes EphA2‐mediated endothelial‐to‐mesenchymal transition in the ovarian tumor microenvironment

open access: yesMolecular Oncology, EarlyView.
Loss of primary cilia in endothelial cells promotes EndMT and vascular abnormalities in the ovarian tumor microenvironment through EphA2 activation. Using human samples, in vitro models, and endothelial‐specific Kif3a‐knockout mice, we show that primary cilia loss drives the acquisition of cancer‐associated fibroblast‐like phenotypes, thereby ...
Jin Gu Cho   +11 more
wiley   +1 more source

Cell fusion in the pathogenesis of COVID-19

open access: yesMilitary Medical Research, 2021
You Zheng   +3 more
doaj   +1 more source

Nurses' attitudes toward death in Oman: Prevalence and correlates in a nationwide sample. [PDF]

open access: yesPalliat Care Soc Pract
Lazarus ER   +5 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy